Sanofi (SNYNF) Gets a Buy From UBS
DBS Maintains Sanofi(SNY.US) With Buy Rating, Announces Target Price $64
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Boston Scientific (BSX) and Sanofi (OtherSNYNF)
Kepler Capital Sticks to Its Hold Rating for Sanofi (SNYNF)
BofA Securities Maintains Sanofi(SNY.US) With Buy Rating
Bank of America Securities Sticks to Their Buy Rating for Sanofi (SNY)
Sanofi's Strong Growth Prospects and Strategic Initiatives Justify Buy Rating
Sanofi Target Raised to EUR100 From EUR85 by Deutsche Bank
Deutsche Bank Upgrades Sanofi(SNY.US) to Hold Rating
Bernstein Remains a Buy on Sanofi (SNYNF)
Analysts Offer Insights on Healthcare Companies: Sumitomo Dainippon Pharma Co (OtherDNPUF) and Sanofi (OtherSNYNF)
Sanofi's Promising Future: Buy Rating Backed by Strategic Moves and Strong Pipeline
J.P. Morgan Sticks to Their Hold Rating for Sanofi (SNYNF)
UBS Sticks to Its Buy Rating for Sanofi (SNYNF)
J.P. Morgan Remains a Hold on Sanofi (SNYNF)
Berenberg Bank Sticks to Their Buy Rating for Sanofi (SNYNF)
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Cencora (COR)
Promising Potential: Sanofi's Strong Pipeline and Strategic Market Focus Drive Buy Rating
Sanofi (SNYNF) Gets a Buy From Jefferies
Sanofi (SNYNF) Gets a Hold From J.P. Morgan